By Jennifer Plitsch, Alexander Hastings and Ian Brekke ( March 20, 2018, 11:56 AM EDT) -- A generic pharmaceutical distributor, Acetris Health LLC, has challenged the final determination of U.S. Customs and Border Protection that Acetris' generic prescription drug, Rosuvastatin Calcium tablets, is a product of India, the place where the active pharmaceutical ingredient (API) is produced. If successful, the challenge in the U.S. Court of International Trade could have a meaningful impact on decisions about where to manufacture API for the very broad range of drug products sold to the U.S. government....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.